Why Inovio's Positive Q4 Update Didn't Impress Investors

Keith Speights, The Motley Fool
·3-min read
Why Inovio's Positive Q4 Update Didn't Impress Investors

Inovio Pharmaceuticals (NASDAQ: INO) shares are up nearly 25% year to date. That's great -- except the stock was up more than 90% in early February. Investors hoping for good news got some with Inovio's fourth-quarter update after the market closed on Monday.